标普和纳斯达克内在价值 联系我们

Response Oncology, Inc. ROIX OTC

Other OTC • Healthcare • Medical - Care Facilities • US • USD

SharesGrow Intrinsic Value
N/A
Negative cash flow

Response Oncology, Inc. (ROIX) 是一家上市公司 属于 医疗保健 板块,经营于 Medical - Care Facilities 行业. 现任CEO为 Charles E. Sweet.

ROIX 拥有 IPO日期为 2000-01-03, 10 名全职员工, 在 Other OTC, 市值为 $12.00.

关于 Response Oncology, Inc.

Response Oncology, Inc. does not have significant operations. The company, along its wholly owned and majority owned subsidiaries, operated as a comprehensive cancer management company. As of May 20, 2002, the company has liquidated substantially all of its operating assets and anticipates that the remaining assets would be liquidated and all wind-down activities completed by the end of 2002. Prior to the sale of its assets, it provided: advanced cancer treatment services through outpatient facilities known as IMPACT Centers under the direction of practicing oncologists; owned the assets of and managed the nonmedical aspects of oncology practices; compounded and dispensed pharmaceuticals to certain oncologists for a fixed or cost plus fee; and conducted outcomes research on behalf of pharmaceutical manufacturers. The company was incorporated in 1984 and is based in Memphis, Tennessee.

公司详情
所属板块医疗保健
细分行业Medical - Care Facilities
国家美国
交易所Other OTC
货币USD
IPO日期2000-01-03
首席执行官Charles E. Sweet
员工数10
交易信息
当前价格$0.00
市值$12.00
52周区间1.0E-6-1.0E-6
Beta-19.14
ETF
ADR
CUSIP761232305
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言